Activation of the classical complement pathway represents an effector mechanism of intestinal ischemia/reperfusion injury. Mice deficient in complement receptors 1 and 2 fail to produce a component of the natural antibody repertoire that binds to ischemiaconditioned tissues and activate complement. In contrast, mice prone to autoimmunity display accelerated and enhanced tissue injury that results from the binding of autoantibodies to injured tissues. Our experiments demonstrate that naturally occurring antibodies and autoantibodies mediate tissue injury only after an organ has been subjected to a stressor such as ischemia.
Introduction
Tissue injury due to ischemia and subsequent reperfusion events is a common pathology that occurs in multiple clinical conditions. Organ ischemia induces immediate cellular injury that is significantly magnified by the return of blood flow and can lead to a systemic inflammatory response that damages remote organs as well. Due to the sensitivity of the mucosal surfaces, ischemia/reperfusion (I/R)-induced injury is exceptionally prominent in the intestine and frequently is followed by liver and lung [damage.
Mesenteric I/R-induced mucosal tissue injury is mediated by at least two components, neutrophil infiltration and complement activation. Initial studies showed protection from I/R-induced injury after neutrophil depletion [Hernandez, 1987 #107; Simpson, 1993 #127] . The involvement of complement activation in the mucosal damage was shown by the lack of damage in complement deficient mice (C3 or C4-/-) or Take-Home messages:
• Complement inhibitors attenuate mesenteric ischemia/reperfusion induced tissue damage.
• Classical complement pathway activation mediates a significant portion of mesenteric ischemia/reperfusion-induced tissue damage.
• Natural antibody repertoire contains antibodies that recognize ischemiaconditioned tissues, activate complement and cause tissue damage.
• Autoantibodies that recognize negatively charged phospholipids, DNA and histones bind to ischemia-conditioned tissues, activate complement and confer tissue damage.
after treatment with cobra venom factor that depletes C3 (1) . Treatment with soluble Crry-Ig allowed neutrophil infiltration without significant tissue damage indicating that the presence of neutrophils is not sufficient for tissue damage (2) . These studies also showed complement activation is critical to the induction of local mucosal damage and resulted in decreased systemic neutrophil activation as well (2) . Inflammatory mediators of the complement pathway, such as the anaphylotoxin C5a, are known to be required for damage to remote organs including the lungs in response to mesenteric IR (3, 4).
Complement in Tissue Injury
The exact mechanism of complement activation during intestinal IR remains unclear as there is evidence that more than one complement pathway (classical, alternative or lectin) may become activated and enhance tissue injury (1, 5, 6) . However, two observations have strongly implicated the classical pathway in this process. The first is that intestinal IR injury is significantly decreased in RAG-1-/-mice, and reconstitution of these Ig deficient mice with purified IgM natural antibody to normal levels restores IRinduced injury (1). The second is that mice with normal levels of natural antibody, but in which the gene encoding complement C4 is inactivated (C4-/-), are protected from injury (1) . From these and other findings, it has been proposed that natural antibodies bind to neo-antigen(s) revealed on the surface membrane of cells subjected to ischemia and subsequently activate complement by recruiting C1 and then cleaving C4 (1). This is followed by the generation of complement C3 and C5 activation fragments with ensuing increases in adhesion molecule expression and release of a cascade of inflammatory mediators, including leukotriene B4 and others (2, 6, 7).
The complement system may be important not only in the effector phases of tissue injury, as discussed above, but also in the development of a pathogenic subset of natural antibodies that recognize neo-antigens on ischemic tissue and then initiate intestinal IR injury. Complement receptor type 2 (CR2/CD21) is an important membrane receptor that greatly enhances B cell receptor (BCR) mediated activation by binding complement iC3b/C3d-decorated antigens and engaging the BCR/CR2/CD19/CD81 signaling complex (8) . This recognition mechanism lowers the threshold for activation of B cells (9) . In mice, CR2 is encoded along with the larger complement receptor type 1 (CR1) by the Cr2 gene, which produces both proteins through alternative splicing of a common mRNA (10, 11) . CR2-/-mice demonstrate a substantial defect in the generation of IgG switched isotype responses (12, 13) as well as impaired B cell memory following immunization with T-dependent antigens (13, 14) . To determine if CR2 plays a role in mesenteric IR, Cr2-/-mice were subjected to intestinal IR injury and were shown to be protected from the induction of tissue injury (6) . Because the levels of complement molecules and complement activation are normal in Cr2-/-mice, other factors were considered to be responsible for this protection.
The defect was shown to lie in an altered repertoire of natural antibodies because infusion of IgM and IgG purified from the serum of wild type C57BL/6 mice in to Cr2-/-mice prior to the ischemic phase resulted in reconstitution of the IR-induced injury (6).
Of interest, transferred IgM and IgG each contributed to different aspects of tissue injury but together allowed the development of a complete injury phenotype (6) . These findings demonstrated a previously unrecognized role for complement receptors in the development within the natural antibody repertoire of a tissue injury-inducing subset of antibodies.
Autoantibodies in Tissue Injury
The specific antibodies involved in I/R injury and the composition of the target antigen, to which recognition is lacking in Cr2-/-mice, are unknown. Since antiphospholipid antibodies have been shown to mediate fetal growth retardation and loss when injected in to pregnant mice (15, 16) , experiments were performed to determine whether anti-phospholipid antibodies can also reconstitute I/R injury and represent members of the injury-inducing repertoire that is missing in Cr2-/-mice. Both murine and human monoclonal and polyclonal antibodies against negatively-charged phospholipids can reconstitute mesenteric I/R-induced intestinal and lung tissue damage in Cr2-/-mice (17). As indicated in Table 1 , antibodies against β2 glycoprotein I also restore local and remote tissue damage in the Cr2-/-mice. Unlike Cr2-/-mice, reconstitution of I/R tissue damage in the IR injury-resistant Rag-1-/-mouse required the infusion of both anti-β2 glycoprotein I and anti-phospholipid antibody ( (17) and Table   1 ). Therefore, anti-phospholipid antibodies can bind to tissues subjected to I/R insult and mediate tissue damage.
Autoantibodies have affinity and self-antigen recognition pattern similar to natural antibodies. Therefore, it is likely that autoimmunity prone mice expressing high titers of autoantibodies should have enhanced I/R-induced injury. The MRL/lpr mouse develops clinical and serologic features similar to human systemic lupus erythematosus.
The production of autoantibodies with multiple specificities including ssDNA, dsDNA, Sm, chromatin, RNA protein complexes and phospholipids typifies the disease (18) . The C57BL/6-lpr/lpr (B6.MRL/lpr) mouse shows lymphadenopathy and autoimmunity although the levels of certain autoantibodies are lower than those in the MRLlpr/lpr mouse (19, 20) . It was hypothesized that autoantibodies present in the sera of mice with systemic autoimmunity should initiate I/R-induced organ injury in a fashion similar to natural antibodies. This hypothesis predicted that autoimmunity-prone mice should The fact that natural antibodies and various autoantibodies mediate the intestinal ischemia reperfusion injury should not be generalized to other target organ injuries. The kidneys of RAG-/-mice are not resistant to IR injury implying that neither immunoglobulin nor mature T cells are relevant in this injury (22) . At this point more information is needed on various target organ models of tissue injury to acquire a complete picture of the involved mechanisms.
Based on the above information we propose that stress or injury alters the lipid membrane of cells such that certain antibodies found in the natural antibody repertoire and autoantibodies bind the cell surface and activate the complement cascade (Fig. 1) .
The ensuing complement activation leads two a two-pronged response by inducing direct 
